Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/24412
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRanawaka, U.K.
dc.date.accessioned2022-02-10T04:14:58Z
dc.date.available2022-02-10T04:14:58Z
dc.date.issued2022
dc.identifier.citationClinical Medicine (Lond.). 2022; 22(1):18-20.en_US
dc.identifier.issn1470-2118
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/24412
dc.descriptionIndexed in MEDLINE.en_US
dc.description.abstractA large majority of neurological infections remain undiagnosed worldwide. Emerging and re-emerging infections are likely to be responsible for a significant proportion of these. Over the last two decades, several new organisms producing neurological infection and the neurotropic potential of many other known pathogens have been identified. Large outbreaks caused by re-emerging pathogens such as Chikungunya virus, Zika virus and Ebola virus have led to better delineation of their neurological manifestations. Recognition of the pandemic potential of emerging pathogens and an improved understanding of their host-vector-environment interactions would help us be better prepared to meet these emerging threats.en_US
dc.language.isoenen_US
dc.publisherThe Royal College of Physicians of Londonen_US
dc.subjectemerging infectionsen_US
dc.subjectneurological infectionsen_US
dc.subjecttropical infectionsen_US
dc.titleEmerging tropical neurological infectionsen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
clinmed-22-1-18.pdf89.7 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.